Amiodarone pneumonitis A clinical case report

Authors

  • Nuno Germano Interno do Internato Complementar de Medicina Interna, Serviço de Medicina e Doenças Infecciosas Hospital de Curry Cabral, Lisboa
  • Maria do Carmo Catarino Assistente Hospitalar de Medicina Interna, Serviço de Medicina e Doenças Infecciosas Hospital de Curry Cabral, Lisboa
  • Rogélia Paula Mendonça Assistente Hospitalar de Medicina Interna Serviço de Medicina e Doenças Infecciosas Hospital de Curry Cabral, Lisboa

Keywords:

amiodarone, hypersensitivity pneumonitis

Abstract

Amiodarone is an anti-arrhythmic drug that causes many
side effects, even when used in low doses (200mg/day).
The most important non-cardiologic side effect is hypersensitivity pneumonitis.
We present a clinic case of a man, treated with amiodarone for one year, who was admitted with a hypersensitivity
pneumonitis.
The patient was treated with systemic corticosteroids
and amiodarone was suspended, due to the severity of the
pulmonary lesions. He had a favourable evolution with
regression of the lesions.

Downloads

Download data is not yet available.

References

Podrid PJ. Amiodarone: reevaluation of an old drug. Ann Intern Med 1995;122:689-700.

Daniel H. Miller MA. Parker R. Doering P. Pieper JA. Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy 1998; 18(6 Pt 2): 138S-145S.

Ben-Noun. Drug-induced respiratory disorders: incidence, prevention and management. Drug Saf 2000; 23(2):143-164.

Miller JM. Zipes DP. Management of the patient with cardiac arrhythmias. In: Braunwald E. Zipes DP. Libby P. eds. Heart Disease: a textbook

of cardiovascular medicine. Philadelphia: W.B. Saunders Company 2001: 700-766

Additional Files

Published

2002-03-29

How to Cite

1.
Germano N, Catarino M do C, Mendonça RP. Amiodarone pneumonitis A clinical case report. RPMI [Internet]. 2002 Mar. 29 [cited 2024 Nov. 21];9(1):28-30. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1844

Issue

Vol. 9 No. 1 (2002): Janeiro/ Março

Section

Case Reports

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Medicina Interna

Open Access

Most read articles by the same author(s)